AAAAAA

   
Results: 1-9 |
Results: 9
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT
Authors: Franzius, C Daldrup-Link, HE Sciuk, J Rummeny, EJ Bielack, S Jurgens, H Schober, O
Citation: C. Franzius et al., FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT, ANN ONCOL, 12(4), 2001, pp. 479-486
High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
Authors: Sauerbrey, A Bielack, S Kempf-Bielack, B Zoubek, A Paulussen, M Zintl, F
Citation: A. Sauerbrey et al., High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma, BONE MAR TR, 27(9), 2001, pp. 933-937
SV40 sequences in human osteosarcoma of German origin
Authors: Heinsohn, S Scholz, RB Weber, B Wittenstein, B Werner, M Delling, G Kempf-Bielack, B Setlak, P Bielack, S Kabisch, H
Citation: S. Heinsohn et al., SV40 sequences in human osteosarcoma of German origin, ANTICANC R, 20(6B), 2000, pp. 4539-4545
High-activity Samarium-153-EDTMP therapy in unresectable osteosarcoma
Authors: Franzius, C Bielack, S Sciuk, J Vollet, B Jurgens, H Schober, O
Citation: C. Franzius et al., High-activity Samarium-153-EDTMP therapy in unresectable osteosarcoma, NUKLEARMED, 38(8), 1999, pp. 337-340
The course of fibrinolytic proteins in children with malignant bone tumours
Authors: Nowak-Gottl, U Munchow, N Klippel, U Paulussen, M Bielack, S Ullrich, K Ehrenforth, S
Citation: U. Nowak-gottl et al., The course of fibrinolytic proteins in children with malignant bone tumours, EUR J PED, 158, 1999, pp. S151-S153
Neoadjuvant therapy for localized extremity osteosarcoma. Experience of the Cooperative Osteosarcoma Study Group COSS with 925 patients
Authors: Bielack, S Kempf-Bielack, B Schwenzer, D Birkfellner, T Delling, G Ewerbeck, V Exner, GU Fuchs, N Gobel, U Graf, N Heise, U Helmke, K von Hochstetter, AR Jurgens, H Maas, R Munchow, N Salzer-Kuntschik, M Treuner, J Veltmann, U Werner, M Winkelmann, W Zoubek, A Kotz, R
Citation: S. Bielack et al., Neoadjuvant therapy for localized extremity osteosarcoma. Experience of the Cooperative Osteosarcoma Study Group COSS with 925 patients, KLIN PADIAT, 211(4), 1999, pp. 260-270
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow
Authors: Zander, AR Zabelina, T Kroger, N Renges, H Kruger, W Loliger, C Durken, M Stockschlader, M de Wit, M Wacker-Backhaus, G Bielack, S Jaburg, N Russmann, B Erttmann, R Kabisch, H
Citation: Ar. Zander et al., Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow, BONE MAR TR, 23(9), 1999, pp. 889-893
Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma
Authors: Sluga, M Windhager, R Lang, S Heinzl, H Bielack, S Kotz, R
Citation: M. Sluga et al., Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma, CLIN ORTHOP, (358), 1999, pp. 120-127
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Authors: Kroger, N Kruger, W Wacker-Backhaus, G Hegewisch-Becker, S Stockschlader, M Fuchs, N Russmann, B Renges, H Durken, M Bielack, S de Wit, M Schuch, G Bartels, H Braumann, D Kuse, R Kabisch, H Erttmann, R Zander, AR
Citation: N. Kroger et al., Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia, BONE MAR TR, 22(11), 1998, pp. 1029-1033
Risultati: 1-9 |